Clinical Trial Update: Sirolimus Effect on Hypertrophic Syndromes Related Gene PIK3CA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of sirolimus on hypertrophic syndromes related to PIK3CA has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pik3ca-related Overgrowth Spectrum

Drugs mentioned

• Rapamune (sirolimus) (sirolimus)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Segmental Overgrowth Disorders Due to PIK3CA | Phase 2 | Status: COMPLETED